Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies

BACKGROUND: Heterogeneity in drug access throughout Europe may be influenced by differences in drug-assessment strategies. The EUnetHTA’s assessment core model (EUnetHTA-core) and the EVIDEM’s multicriteria framework are reference methodologies in this context, the latter including a wider compromis...

Descripción completa

Detalles Bibliográficos
Autores principales: Elvira, David, Obach, Mercè, Pontes, Caridad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364048/
https://www.ncbi.nlm.nih.gov/pubmed/34391431
http://dx.doi.org/10.1186/s12913-021-06784-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364048/
https://www.ncbi.nlm.nih.gov/pubmed/34391431
http://dx.doi.org/10.1186/s12913-021-06784-8

Ejemplares similares